pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-137 |
Genomic Coordinates | chr1: 98046070 - 98046171 |
Description | Homo sapiens miR-137 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-137 |
Sequence | 59| UUAUUGCUUAAGAAUACGCGUAG |81 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FMNL2 | ||||||||||||||||||||
Synonyms | FHOD2 | ||||||||||||||||||||
Description | formin like 2 | ||||||||||||||||||||
Transcript | NM_052905 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FMNL2 | |||||||||||||||||||||
3'UTR of FMNL2 (miRNA target sites are highlighted) |
>FMNL2|NM_052905|3'UTR 1 ACCTGAGACTGGCCTGCATGAATACAGGGTGTGCGTGAATGAAACTGCCCACATGAACTTTATGTGCTACGATTTAACTG 81 CAGCCTTGAACACACACAAAAATATTCTTAAGGGCTCAGATTTAGCAAACACGGAAGAATTTTAAAATGAGCTCTCCTTT 161 CAACCCTTGTTAACAAGTGCCTAAAAATGGAAGTACCTGTTCAGATTAATCAAAGCAATAGGATTTGATTTGATTAGGTA 241 TCTTTTTACACCAGTATGTTATTTTTAACCAAAATGTAAAGTTCTTATTAAACTCATTACCTGCCATTGTGATTGTCCCA 321 TCATGGCCCACCTGGTTTCCTGATGTTGTAAATAACATCAATGCATCTGCTGTGGGTCCTTTGCTGAGATGTCTTCGAAG 401 GAATTTTGTTTTAGCCATATCCATCAACTTTGTATTTTACTTGCAATTTGGAAGAAGGAAAGTCACATGATGAAACTCCT 481 TTTGTCTATAACCAGGCCCTGGCAAAGTGCAAACAGGATGCAACTGCAGTGGCACAAAGGTCACTCAATCCTTTGTTTCC 561 AGTTTCACATTCTACTACTTCTGCGCTAGAGAACGATGCTCTGTGAGAGGCATTCACTAGTATGAATGTGGGGATATAGT 641 GTATAAGACTTATTTGCAGTACTGTGTTCTTCAGCTAGAGGCAGCTTTTTAAATAATGCAAGTGTATTTATTAGCATTAA 721 AATTAACATCTCAGTAATCAGCATTAGCATTTCTGAGGACCATTATTAATTCTGAGAACAGAAATTGGTGCCTTGCAAGG 801 AAGTTTACTAGCTCTATCAACAAGCATTCAAGGTTACATCTGCTAGCAGAGTAGTGTTAGGAACCTGGCCTTACTCTCCT 881 CTGACAATCGCAATTTTTTCTTATTTTTTATAAATTCAAGAAGATACACTTGGCATCGTGTATCGAGGCTAAGTTTTTCA 961 TGCATTTCCCAGACTACTTATGGAGAATTGCAGTTTAAGTTGCTGAAAAGTATTAACATGGTATTAAGCTTAAATAATAC 1041 GTAATGGGACTAGATGGCCCACTAAGCCACTGTTATTTTCCTTCCTCTCTGGCAGGGCACTTGATCCATTCCAAAGTCAA 1121 AAACTGGACTGAAGCTAAATTTGTACTTTTCATAATATACATTCTGCTTCTGGCTTATCTTCTTGGTACATCAATATATT 1201 AATTGTAAAGTTTATTGTATAGTATTTAACCGCTGAAGTTCCTATTTTATGTTGTGCTTATGTGAACCCCTTGGTGAAGG 1281 TCCCTTTTCCTTGGATGTGTAGTTATATGATCTTTTTAAATGTACAGATATTTTGCTATAAAATCGGTGCAGTTTTTTAT 1361 GGTTTTTACACTTCTCTTTAATTCCCACCTAAGCCTCTGGGTAATATTGTAAATATTGTTTTAAAATGCATCAGCCTATG 1441 CTATACAATCTGAATGTTATTTTAACTTATAGTTTTTTTTAATATATATATTTAACTATAAGGACAGTTTAGGGAACAAG 1521 TTACCTACCACATTTCACTTTAGTGTACCTATTTACAGAAAGATTAAACTGCCACCTGCGGGCACATTCCCATAAATGTG 1601 TACTTTACTTTAAAAAGAACATGCCACGATTTTGTCTTTCTGTGGACTCAACATTCACTTCGATTAAAAATAGCAATTTG 1681 ACCAAGTTGGACTTCCACTACAAAGCAGCTGTTTTCCAAAGTTCAATGCTGACATATATGTATATTAAAATAATTGCCTA 1761 TTTATTAATCTACAAATAGACAACGTTGGCATGTTCTTTTCTGTTTGTCTATTAATGGGCCTGCTTCTTAGCAATATTAG 1841 AATGTTTTATAAAAGCAATTCATGTTACTTTTCTGGTCTTTTCATGGCATATGAGCAAATAATAAACTATTTACACTACT 1921 ATTCTGTAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293A , SW620 |
Location of target site | 3'UTR |
Tools used in this research | microRNA.org , miRanda , PicTar , TargetScan |
Original Description (Extracted from the article) |
...
The 3'UTR Region of FMNL2 mRNA Is a Direct Target of miR-137
... - Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; et al., 2013, Gastroenterology. |
Article |
- Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; et al. - Gastroenterology, 2013
BACKGROUND & AIMS: Formin-like (FMNL)2 is up-regulated in colorectal tumors and has been associated with tumor progression, but little is known about regulatory mechanisms. We investigated whether microRNAs regulate levels of FMNL2 in colorectal cancer (CRC) cells. METHODS: We used real-time polymerase chain reaction and immunoblot analyses to measure levels of miR-137, high-mobility group AT-hook (HMGA)1, and FMNL2 in CRC cells and tissue samples from patients (n = 50). We used luciferase reporter assays to determine the association between miR-137 and the FMNL2 3' untranslated region, and HMGA1 and the miR-137 promoter. Chromatin immunoprecipitation assays were used to assess direct binding of HMGA1 to the miR-137 promoter. RESULTS: miR-137 and miR-142-3p were predicted to bind FMNL2 based on bioinformatic data. Only the level of miR-137 had a significant inverse correlation with the level of FMNL2 protein in CRC cell lines and tissues. FMNL2 messenger RNA was targeted by miR-137; expression of miR-137 inhibited proliferation and invasion by CRC cells in vitro, and metastasis to liver and intestine by CRC xenografts in nude mice. HMGA1 bound to the promoter of miR-137 and activated its transcription, which reduced levels of FMNL2 in CRC cells. Ectopic expression of miR-137 in CRC cells inhibited phosphorylation of mitogen-activated protein kinase (MAPK) and Akt, which reduced levels of matrix metalloproteinase 2, matrix metalloproteinase 9, and vascular endothelial growth factor; it also reduced invasiveness of CRC cells, inhibiting signaling via phosphatidylinositol-4,5-bisphosphate 3-kinase, Akt, and MAPK. CONCLUSIONS: Levels of miR-137 and HMGA1 are reduced, and levels of FMNL2 are increased, in CRC samples compared with adjacent normal mucosa. In CRC cells, miR-137 targets FMNL2 messenger RNA and is regulated by the transcription factor HMGA1. Expression of miR-137 reduces CRC cell invasion in vitro and metastasis of tumor xenografts in mice. FMNL2 appears to activate phosphatidylinositol-4,5-bisphosphate 3-kinase, protein kinase B (Akt), and MAPK signaling pathways.
LinkOut: [PMID: 23201162]
|
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
140 hsa-miR-137 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT002489 | E2F6 | E2F transcription factor 6 | 4 | 1 | ||||||||
MIRT002490 | CDK6 | cyclin dependent kinase 6 | 4 | 7 | ||||||||
MIRT004004 | NCOA2 | nuclear receptor coactivator 2 | 4 | 1 | ||||||||
MIRT004579 | KDM1A | lysine demethylase 1A | 5 | 3 | ||||||||
MIRT005485 | CDC42 | cell division cycle 42 | 4 | 4 | ||||||||
MIRT005605 | CTBP1 | C-terminal binding protein 1 | 4 | 1 | ||||||||
MIRT005883 | MITF | melanogenesis associated transcription factor | 3 | 1 | ||||||||
MIRT006329 | PTGS2 | prostaglandin-endoperoxide synthase 2 | 2 | 1 | ||||||||
MIRT006957 | ESRRA | estrogen related receptor alpha | 1 | 1 | ||||||||
MIRT007068 | ZNF804A | zinc finger protein 804A | 1 | 1 | ||||||||
MIRT007092 | YBX1 | Y-box binding protein 1 | 3 | 3 | ||||||||
MIRT007252 | CSE1L | chromosome segregation 1 like | 2 | 1 | ||||||||
MIRT007346 | PXN | paxillin | 3 | 1 | ||||||||
MIRT053056 | GLIPR1 | GLI pathogenesis related 1 | 3 | 1 | ||||||||
MIRT053225 | MET | MET proto-oncogene, receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT054547 | FUNDC1 | FUN14 domain containing 1 | 3 | 1 | ||||||||
MIRT054568 | BNIP3L | BCL2 interacting protein 3 like | 3 | 1 | ||||||||
MIRT090615 | PLS1 | plastin 1 | 2 | 2 | ||||||||
MIRT093393 | TMA16 | translation machinery associated 16 homolog | 2 | 2 | ||||||||
MIRT109230 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 6 | ||||||||
MIRT153687 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT170929 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT219251 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT259552 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT271869 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT280623 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 8 | ||||||||
MIRT293284 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT314017 | PAPD7 | poly(A) RNA polymerase D7, non-canonical | 2 | 8 | ||||||||
MIRT374677 | AGO4 | argonaute 4, RISC catalytic component | 2 | 2 | ||||||||
MIRT437385 | FMNL2 | formin like 2 | 1 | 1 | ||||||||
MIRT437406 | RORA | RAR related orphan receptor A | 1 | 1 | ||||||||
MIRT437423 | KIT | KIT proto-oncogene receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT437424 | AKT2 | AKT serine/threonine kinase 2 | 5 | 4 | ||||||||
MIRT437425 | TGFB2 | transforming growth factor beta 2 | 3 | 1 | ||||||||
MIRT437804 | SERPINA3 | serpin family A member 3 | 1 | 1 | ||||||||
MIRT437978 | COX2 | cytochrome c oxidase subunit II | 3 | 1 | ||||||||
MIRT438078 | TRIM13 | tripartite motif containing 13 | 4 | 1 | ||||||||
MIRT438287 | TBX3 | T-box 3 | 1 | 1 | ||||||||
MIRT438288 | KLF4 | Kruppel like factor 4 | 1 | 1 | ||||||||
MIRT438537 | MTDH | metadherin | 2 | 1 | ||||||||
MIRT438757 | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 | 2 | 1 | ||||||||
MIRT442564 | CCDC59 | coiled-coil domain containing 59 | 2 | 2 | ||||||||
MIRT442778 | JAG1 | jagged 1 | 2 | 2 | ||||||||
MIRT444302 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 2 | ||||||||
MIRT446969 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT448824 | FKBP1A | FK506 binding protein 1A | 2 | 4 | ||||||||
MIRT453617 | SNRPE | small nuclear ribonucleoprotein polypeptide E | 2 | 4 | ||||||||
MIRT459217 | MRPS21 | mitochondrial ribosomal protein S21 | 2 | 2 | ||||||||
MIRT463490 | ZC3H11A | zinc finger CCCH-type containing 11A | 2 | 12 | ||||||||
MIRT470084 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT475876 | H3F3C | H3 histone family member 3C | 2 | 10 | ||||||||
MIRT475912 | H3F3B | H3 histone family member 3B | 2 | 8 | ||||||||
MIRT476669 | FUT11 | fucosyltransferase 11 | 2 | 10 | ||||||||
MIRT477346 | EOGT | EGF domain specific O-linked N-acetylglucosamine transferase | 2 | 4 | ||||||||
MIRT477596 | EIF1 | eukaryotic translation initiation factor 1 | 2 | 10 | ||||||||
MIRT478367 | DDI2 | DNA damage inducible 1 homolog 2 | 2 | 2 | ||||||||
MIRT479111 | CNN2 | calponin 2 | 2 | 2 | ||||||||
MIRT482926 | CTPS2 | CTP synthase 2 | 2 | 2 | ||||||||
MIRT485083 | SNRK | SNF related kinase | 2 | 12 | ||||||||
MIRT497120 | NBEAL1 | neurobeachin like 1 | 2 | 2 | ||||||||
MIRT498029 | UBXN4 | UBX domain protein 4 | 2 | 8 | ||||||||
MIRT500603 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 4 | ||||||||
MIRT500927 | SSFA2 | sperm specific antigen 2 | 2 | 8 | ||||||||
MIRT504324 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 6 | ||||||||
MIRT504647 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT506304 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | 2 | 6 | ||||||||
MIRT508007 | BCAT1 | branched chain amino acid transaminase 1 | 2 | 4 | ||||||||
MIRT510538 | XKR7 | XK related 7 | 2 | 2 | ||||||||
MIRT513051 | LYPD6 | LY6/PLAUR domain containing 6 | 2 | 6 | ||||||||
MIRT515223 | COX20 | COX20, cytochrome c oxidase assembly factor | 2 | 8 | ||||||||
MIRT519857 | ZFP62 | ZFP62 zinc finger protein | 2 | 6 | ||||||||
MIRT520508 | TRAM2 | translocation associated membrane protein 2 | 2 | 6 | ||||||||
MIRT522047 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 4 | ||||||||
MIRT524479 | CHRM3 | cholinergic receptor muscarinic 3 | 2 | 4 | ||||||||
MIRT526904 | ZNF772 | zinc finger protein 772 | 2 | 6 | ||||||||
MIRT527862 | SLC39A14 | solute carrier family 39 member 14 | 2 | 2 | ||||||||
MIRT528601 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT532950 | ZNF24 | zinc finger protein 24 | 2 | 4 | ||||||||
MIRT536275 | LMOD2 | leiomodin 2 | 2 | 2 | ||||||||
MIRT537045 | GRAMD4 | GRAM domain containing 4 | 2 | 2 | ||||||||
MIRT537124 | GOLGA3 | golgin A3 | 2 | 4 | ||||||||
MIRT538884 | BTBD1 | BTB domain containing 1 | 2 | 2 | ||||||||
MIRT541457 | AURKA | aurora kinase A | 2 | 2 | ||||||||
MIRT542924 | HOXC8 | homeobox C8 | 2 | 2 | ||||||||
MIRT544580 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | 2 | 4 | ||||||||
MIRT545175 | RFTN2 | raftlin family member 2 | 2 | 2 | ||||||||
MIRT545248 | GTF2E1 | general transcription factor IIE subunit 1 | 2 | 2 | ||||||||
MIRT546473 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT547523 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT548071 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT548200 | FNIP1 | folliculin interacting protein 1 | 2 | 2 | ||||||||
MIRT551216 | CIDEC | cell death inducing DFFA like effector c | 2 | 2 | ||||||||
MIRT553046 | USP28 | ubiquitin specific peptidase 28 | 2 | 2 | ||||||||
MIRT553875 | SUPT7L | SPT7 like, STAGA complex gamma subunit | 2 | 4 | ||||||||
MIRT554026 | SPCS3 | signal peptidase complex subunit 3 | 2 | 2 | ||||||||
MIRT554153 | SLX4 | SLX4 structure-specific endonuclease subunit | 2 | 2 | ||||||||
MIRT554192 | SLC35E2B | solute carrier family 35 member E2B | 2 | 2 | ||||||||
MIRT554362 | SFXN5 | sideroflexin 5 | 2 | 4 | ||||||||
MIRT555349 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | 2 | 2 | ||||||||
MIRT555822 | PAX9 | paired box 9 | 2 | 2 | ||||||||
MIRT555866 | PAIP1 | poly(A) binding protein interacting protein 1 | 2 | 2 | ||||||||
MIRT555931 | NUP43 | nucleoporin 43 | 2 | 2 | ||||||||
MIRT555993 | NFYB | nuclear transcription factor Y subunit beta | 2 | 2 | ||||||||
MIRT556429 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT556582 | LHFPL2 | LHFPL tetraspan subfamily member 2 | 2 | 4 | ||||||||
MIRT557220 | HNRNPDL | heterogeneous nuclear ribonucleoprotein D like | 2 | 2 | ||||||||
MIRT558490 | DBN1 | drebrin 1 | 2 | 2 | ||||||||
MIRT560986 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | 2 | 2 | ||||||||
MIRT562291 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT564093 | TLR3 | toll like receptor 3 | 2 | 2 | ||||||||
MIRT565312 | TMEM41A | transmembrane protein 41A | 2 | 2 | ||||||||
MIRT565424 | TEF | TEF, PAR bZIP transcription factor | 2 | 2 | ||||||||
MIRT566946 | LIMCH1 | LIM and calponin homology domains 1 | 2 | 2 | ||||||||
MIRT572369 | ATOX1 | antioxidant 1 copper chaperone | 2 | 2 | ||||||||
MIRT686211 | ZNF267 | zinc finger protein 267 | 2 | 2 | ||||||||
MIRT686935 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT687448 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT710856 | COQ7 | coenzyme Q7, hydroxylase | 2 | 2 | ||||||||
MIRT719484 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT719813 | TXNDC17 | thioredoxin domain containing 17 | 2 | 2 | ||||||||
MIRT720076 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | 2 | 2 | ||||||||
MIRT723920 | ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif 15 | 2 | 2 | ||||||||
MIRT731305 | CUL4A | cullin 4A | 3 | 1 | ||||||||
MIRT732128 | BMP7 | bone morphogenetic protein 7 | 2 | 1 | ||||||||
MIRT732466 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 3 | 0 | ||||||||
MIRT732962 | TNC | tenascin C | 1 | 0 | ||||||||
MIRT734856 | KDM4A | lysine demethylase 4A | 3 | 0 | ||||||||
MIRT735625 | MEF2A | myocyte enhancer factor 2A | 2 | 0 | ||||||||
MIRT735795 | IL6 | interleukin 6 | 3 | 0 | ||||||||
MIRT736333 | DELE1 | KIAA0141 | 2 | 0 | ||||||||
MIRT736610 | RUNX2 | runt related transcription factor 2 | 3 | 0 | ||||||||
MIRT736830 | NOTCH1 | notch 1 | 3 | 0 | ||||||||
MIRT736888 | KCNA2 | potassium voltage-gated channel subfamily A member 2 | 3 | 0 | ||||||||
MIRT737349 | EGFR | epidermal growth factor receptor | 3 | 0 | ||||||||
MIRT755368 | GLS | glutaminase | 2 | 1 | ||||||||
MIRT755431 | SPHK2 | sphingosine kinase 2 | 3 | 1 | ||||||||
MIRT756119 | USP30 | ubiquitin specific peptidase 30 | 4 | 1 | ||||||||
MIRT756144 | XIAP | X-linked inhibitor of apoptosis | 3 | 1 | ||||||||
MIRT756170 | COL5A1 | collagen type V alpha 1 chain | 3 | 1 | ||||||||
MIRT756171 | FSTL1 | follistatin like 1 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|